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ABSTRACT 
     The gastrointestinal (GI) microbiota in healthy cats is altered in IBD. Little research has 
been performed to identify whether specific bacterial groups are associated with small cell GI 
lymphoma (LSA). 
     Fourteen cats with IBD and 14 cats with small cell GI LSA were included in this 
retrospective case control study. A search of the medical records was performed to identify 
cats diagnosed with IBD and with GI LSA. Bacterial groups identified by FISH in GI 
biopsies were compared between cohorts and correlated to CD11b+ and NF-B expression. 
    Fusobacterium spp. were higher in cats with small cell GI LSA in ileal and colonic 
adherent mucus, and combined colonic compartments compared to cats with IBD. 
Bacteroides spp. were higher in ileal adherent mucus and 3 combined ileal compartments of 
cats with small cell GI LSA. There were significant correlations between Fusobacterium spp. 
totals and CD11b+ cell and NF-B expression.   
     The bacterial alterations appreciated might be influential in development of small cell GI 
LSA, and should drive further studies to elucidate the effects of microbial-mediated 
inflammation on GI cancer progression. 
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CHAPTER 1.  INTRODUCTION  
Alterations in the Microbiome Relative to Gastrointestinal Disease Progression and  
Inflammatory Mediators          
 
     Diagnosis of small cell gastrointestinal (GI) lymphoma (LSA) in cats increased six-fold 
over a four-decade period spanning from 1964 through 2004, highlighting the growing 
clinical importance of this disease.1 Frequent identification of the disease continues today, 
most notably in cats with chronic weight loss, vomiting, decreased appetite and diarrhea. 
Small cell GI LSA closely resembles feline inflammatory bowel disease (IBD) in its clinical 
presentation,2 with both diseases having poorly defined etiologies. Various risk factors 
including genetic and molecular alterations,3-5 diet,3,6,7 and chronic inflammation8-10 have 
been linked to the development of both disorders. Still other studies have suggested an 
association between chronic mucosal inflammation and the progression of IBD to 
pronounced dysplasia in the GI tract.11-14   
 
     Although the microbiota is intimately involved in GI homeostasis and immune balance, 
several studies in animal models and humans with cancer incriminate bacterial-induced 
chronic intestinal inflammation as promoting a local environment favorable for malignant 
transformation, including lymphomagenesis.11-14  Increased numbers of mucosal-adherent 
bacteria were observed in cats with duodenal IBD,10 while invasive bacteria were observed 
within blood vessels and serosa of cats with large cell lymphoma.9  These collective 
observations suggest that altered microbial composition (e.g. dysbiosis) is associated with  
development of benign mixed mucosal inflammation (lymphoplasmacytic enteritis with IBD) 
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and GI lymphoid malignancy.9,10,15-18  Microbial imbalances have also been implicated in the 
pathogenesis of approximately 20% of all human malignancies, including GI neoplasia such 
as colorectal adenocarcinomas and gastric carcinomas.19-21 Both chronic, high-grade 
inflammation of disorders such as feline IBD, and lower grade smoldering inflammation 
attributable to pro-inflammatory bacteria (e.g. Helicobacter spp., Enterobacteriaceae, 
Fusobacterium spp.) might drive a tumor-permissive milieu characterized by mucosal 
infiltration with specialized effector cells, including CD11b+ myeloid cell derived 
macrophages, as observed in humans, and rodent models.9,19,21,22 
 
     Differentiated CD11b+ myeloid cells play an important role in tumor progression and 
angiogenesis in rodent models and humans with colorectal cancer (CRC).19,23 Nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-B), a protein complex of transcription 
factors, is involved in immune regulation, DNA transcription, and pro-inflammatory cytokine 
and chemokine production.24  This protein complex is also involved in activation of effector 
cells through toll-like receptors (TLRs) in response to GI micro-organisms. Dysregulation of 
the activation of NF-B can lead to overproduction of pro-inflammatory cytokines and cell 
transformation, triggering the development of cancers in humans.25-27 
 
     We hypothesized that pro-inflammatory bacteria, including Enterobacteriaceae and 
Fusobacterium spp. are abundant in the intestinal biopsies of cats with small cell GI LSA 
relative to cats with IBD. An objective of this study was to investigate the potential  
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relationship between mucosal bacteria and the mucosal expression of NF-B and infiltrating 
CD11b+ immune cells in GI biopsies of cats with small cell GI LSA versus GI biopsies of 
cats with IBD. 
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CHAPTER 2. MATERIALS AND METHODS  
Study Design 
 
 
     This study was a retrospective study involving 3 study centers, VDx Veterinary 
Diagnostics Laboratory, Davis CA; the University of Camerino Veterinary Teaching 
Hospital, Italy and Iowa State University, Ames IA. The medical records of each facility 
were reviewed to identify cats having GI endoscopic or laparoscopic derived diagnosis of 
histologic IBD or small cell GI LSA from January 2010 to January 2015. Fourteen cats with 
IBD and 14 cats with small cell GI LSA were included in the study. Inclusion criteria was 
comprised of complete medical histories, the performance of hematologic and serum 
biochemical analysis, and measurement of serum T4 in all cats. Serology for Feline 
Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) infections, diagnostic 
imaging, and serum cobalamin levels were also assessed in most cats. Cats were also either 
tested for intestinal parasites via fecal examinations, dewormed or had deworming performed 
in the face of negative fecal examinations before biopsies were collected. All cats in both 
study cohorts tested negative for intestinal parasite ova on fecal examinations. 
Histopathologic examination of intestinal biopsy specimens after hematoxylin-eosin (HE) 
staining and immunophenotyping (e.g. IHC stains for CD21, CD79a [B-lymphocytes] and 
CD3 [T-lymphocytes]) was performed on each cat to determine a final diagnosis of IBD or 
small cell GI LSA. In some instances, there was overlap in immunohistopathologic features 
necessitating performance of polymerase chain reaction for antigen receptor rearrangement 
(PARR) to confirm a final diagnosis of IBD versus small cell GI LSA. 
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Fluorescence in Situ Hybridization 
 
 
     Formalin-fixed embedded tissue sections were mounted on glass slides and evaluated by 
fluorescence in situ hybridization (FISH) as previously described.8  In brief, paraffin-
embedded tissue specimens were deparaffinized using an automated system by passage 
through xylene (3 x 10 min), 100% alcohol (2 x 5 min), 95% ethanol (5 min) and lastly 70% 
ethanol (5 min). The slides were next immediately transported in deionized water to the DNA 
testing laboratory where they were air dried prior to hybridization. FISH probes of interest, 
5’-labeled with either Cy-3 or FITC were reconstituted with DNAse-free water and diluted to 
a working concentration of 5ng/L (Table 1). 
   
     For total bacterial counts, Eub338-FITC was used.28  For other analyses, specific probes 
targeting Clostridium spp. (Erec482),29 Bacteroides-Prevotella group (Bacto1080),30 
Fusobacterium spp. (Fuso0664),31 Enterobacteriaceae (Ebac1790),32  Helicobacter spp. 
(Hel717),33 and Faecalibacterium spp. (Faecali698),34 were labeled with Cy-3 and were 
applied simultaneously with the universal bacterial probe Eub338-FITC. This probe array 
was selected to identify specific bacterial groups and individual bacterial species previously 
shown to be relevant in the pathogenesis of intestinal cancers in humans, rodents, and 
dogs.9,14,19,22,23,27,35-54 
  
     Tissue sections were bathed in 30L of DNA-probe-hybridization buffer mix in a 
hybridization chamber maintained at 54°C overnight (12 hours). Buffer 1 (20mM Tris, 0.9M  
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NaCl, 0.1% SDS, 20% Formamide, 10% Dextran sulfate) was used for the hybridization of 
Eub338, Erec482, Bacto1080, Fuso0664, Ebac1790 and Faecali698. Buffer 2 (20mM Tris, 
0.9M NaCl, 0.1% SDS, 40% Formamide) was used for the hybridization of Hel717. Washing 
was then performed using wash buffer (hybridization buffer without SDS), the slides were 
rinsed with sterile water, then allowed to air-dry, and mounted with SlowFade Gold 
mounting media and 22x22-1 glass cover slip. Probe specificity was confirmed in pilot 
studies by combining the irrelevant probe non-Eub338-FITC with Eub338-Cy-3, and through 
hybridization experiments with pure bacterial isolates to screen for non-selective 
hybridization. 
 
In Situ Quantification of Mucosal Bacteria Associated with Biopsy Specimens 
 
     Bacteria were visualized and quantified using an Eclipse TE2000-E fluorescence 
microscope.  Images were captured with a CoolSnap EZ camera and bacterial enumeration 
was performed using MetaMorph software. A minimum of 3 separate hybridized intestinal 
tissue sections were evaluated for their bacterial content. Bacterial quantification was 
performed in 10 representative mucosal fields of each hybridized tissue section of formalin-
fixed, paraffin embedded biopsy specimens. A hybridized tissue section was first visualized 
at 200x magnification to locate the center of each tissue section. Then surrounding fields of 
bacterial populations were subsequently selected, and quantified using a 60x Plan Apo oil 
objective with an optional 1.5x multiplier lens. Bacterial counts were obtained randomly in 3 
mucosal fields in 2 of the 3 hybridized tissue sections, and randomly in 4 views on the third  
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hybridized tissue section, accounting for 10 views for bacterial quantification in total. The 
ten fields counted included bacteria located within 4 well-defined mucosal compartments: (1) 
bacteria found within free mucus, (2) bacteria localized within adherent mucus, (3) bacteria 
attached to the surface epithelium, and (4) bacteria invasive within the mucosa (Figure 1). 
 
Immunohistochemical Assessment of the Number of CD11b+ Cells and Mucosal NF-B 
Expression 
 
     The number of mucosal CD11b+ myeloid cells, and nuclear factor – kappa B (NF-B) 
expression were quantified in intestinal tissues of all 28 cats. This included 14 cats diagnosed 
with IBD and 14 cats diagnosed with small cell GI LSA. For IHC evaluation, paraffin 
embedded tissue sections were rehydrated and neutralized for endogenous peroxidases with 
3% hydrogen peroxide for 5 minutes followed by rinsing for 5 minutes in distilled water. For 
antigen retrieval, the heat-induced epitope retrieval (HIER) method was selected, on the basis 
of previous experiences showing better results with antigens, such as CD11b+, that might 
require more efficient breakage of methylene bridges formed during formalin fixation and 
allowing antibody to bind.  In brief, slides were incubated in an universal antigen retrieval 
buffer, used in a water bath set to 140°F and allowing the slides to incubate in retrieval 
solution overnight. Non-specific binding was blocked by incubation of slides for 10 minutes 
with a protein-blocking agent before application of the primary antibody. Slides were then 
incubated overnight in a moist-chamber with the following primary antibodies: canine cross-
reactive monoclonal antibody against NF-B (p65)55 diluted 1∶50, and a goat polyclonal  
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to CD11b+ (anti-CD11b+ antibody - ref. N° ab62817) diluted 1∶50. The immunoreaction with 
streptavidin–immunoperoxidase was visualized with 3,3′-diaminobenzidine substrate. 
Tissues were counterstained with Mayer's hematoxylin (Figure 2). For negative IHC controls, 
the primary antibodies were omitted. Sections of feline and canine spleen and tonsil served as  
positive control tissues for both NF-B (p65) and CD11b+ cell staining. Finally, isotype 
controls were used as negative controls to help differentiate eventual non-specific 
background signal from specific antibody signal, by the use of primary antibodies lacking 
specificity to the target, but matching the class and type of the primary antibody used in the 
IHC studies. 
 
     For assessment of intestinal NF-B (p65) and CD11b+ cells, the cells were quantified in 
select compartments of the GI tract biopsies (small intestine: villi, basal crypt area, villus-
crypt junction; large intestine: apical crypt area, basal crypt area). All cellular types were 
evaluated using a light microscope (Carl Zeiss), a×40 objective, a×10 eyepiece, and a square 
eyepiece graticule (10×10 squares, having a total area of 62,500 μm2). Ten appropriate fields 
were chosen for each compartment and arithmetic means were calculated for each intestinal 
region. Results were expressed as IHC positive cells per 62,500 μm2. Cells on the margins of 
the tissue sections were not considered for evaluation to avoid inflation of positive cell 
numbers. 
 
     The numbers of mucosal NF-B (p65) expressing cells and CD11b+ cells were quantified 
using an image-analysis system consisting of the previously mentioned light microscope  
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(Carl Zeiss) attached to a Javelin JE3462 high-resolution camera and a personal computer 
equipped with a Coreco-Oculus OC-TCX frame grabber and high-resolution monitor. 
Computerized color-image analysis was performed by using Image-Pro Plus software. The 
area of each biopsy in all cross sections in every cat was recorded. For each cat, the total  
bioptic area was calculated as the sum of the areas of all fields in all bioptic cross sections on 
one slide. The NF-B (p65) expressing cells and CD11b+ cells were counted per section, and 
stained cell densities were expressed as the number of mononuclear cells per square 
millimeter of analyzed bioptic area.56 
 
Statistical Analysis 
 
     Tabular data were organized by probe, organ, mucosal compartment and disease group. 
Mean, median, standard deviation, minimum, and maximum values were calculated from the 
absolute bacterial counts. Normality of data was assessed visually by histograms and Q-Q 
plots. If data were not found to be normally distributed, they were log-transformed and 
reassessed. Median values were compared among groups for significance using the Wilcoxon 
rank sum test. Analyses were considered significant at P < 0.05. All graphs were constructed 
using non-log-transformed, actual raw data. 
 
     Associations between bacterial numbers (identified by FISH) and the numbers of CD11b+ 
cells and NF-B expressing cells were assessed using Spearman’s rank correlation and tested 
for significance. Significance was determined as P < 0.05. Sample size for enrollment was  
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calculated after consultation with a statistician and was based on the desired power and 
variability in the number of CD11b+ cells and NF-B expressing cells observed in IBD 
versus small cell GI LSA feline cohorts. Randomization of 12 cats per group would give a 
power of 80% to detect differences in expression of CD11b+ cells and NF-B expressing 
cells between cohorts at the .05 significance level. All analyses were made using SAS 9.4. 
 
 
 
Table 1    Oligonucleotide probes used for fluorescence in situ hybridization (FISH) and 
bacterial quantification. 
Probe Target Sequence (5’ → 3’) 
Eub338 Eubacteria GCT GCC TCC CGT AGG AGT 
Erec482 
 
Clostridium coccoides-E. rectale 
cluster 
GCT TCT TAG TCA RGT ACC G 
 
Ebac1790 Enterobacteriaceae CGT GTT TGC ACA GTG CTG 
Bacto1080 Bacteroides spp. 
Prevotella spp. 
GCA CTT AAG CCG ACA CCT 
Hel717 Helicobacter spp. AGG TCG CCT TCG CAA TGA 
GTA 
Faecali698 Faecalibacterium spp. GTG CCC AGT AGG CCG CCT 
TC 
Fuso0664 Fusobacterium spp. CTT GTA GTT CCG CYT ACC TC 
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Figure 1 Mucosal compartments for bacterial quantification. FM, bacteria within free mucus 
within the GI lumen; AM, bacteria within adherent mucus adhered to the epithelia; A, 
bacteria directly attaching to surface epithelia; I, bacteria invasive within the mucosa. Three-
color fluorescence in situ hybridization (FISH) of Bacteroides spp. identified in ileal biopsies 
of a cat with small cell GI LSA. 
Legend: Cy-3-labeled Bacteroides spp. (labeled orange) localized within adherent mucus of 
an ileal biopsy specimen. The mucus is also occupied by other bacteria (total bacteria   
labeled green with FITC-Eub). The dark blue structures are epithelial cell nuclei stained with 
DAPI. 
 
 
 
 
 
 
 
12 
 
 
Figure 2 IHC staining for CD11b+ and NF-κB primary antibodies in ileal and colonic 
biopsies of cats with IBD and small cell GI LSA. (A) CD11b+myeloid cell staining in the 
ileum of a cat with IBD. Cross sectional view of ileal villi after IHC staining with a goat 
polyclonal antibody to CD11b+ as represented by the brown chromophore staining amongst 
the epithelium and in the lamina propria. (B) NF-κB staining in the ileum of a cat with IBD. 
Cross sectional view of ileal villi after IHC staining with a canine cross-reactive monoclonal 
antibody against NF-κB as represented by the brown chromophore staining amongst the 
epithelium and in the lamina propria. (C) CD11b+ staining in the ileum of a cat with small 
cell GI LSA. Longitudinal view of ileal villi after IHC staining with a goat polyclonal 
antibody to CD11b+ as represented by the brown chromophore staining amongst the 
epithelium and in the lamina propria. (D) NF-κB staining in the ileum of a cat with small cell 
GI LSA. Longitudinal view of ileal villi after IHC staining with a canine cross-reactive 
monoclonal antibody against NF-κB as represented by the brown chromophore amongst the 
epithelium and in the lamina propria. (E) CD11b+ staining in the colon of a cat with small 
cell GI LSA. Longitudinal and cross sectional views of colonic mucosa and lamina propria 
after IHC staining with a goat polyclonal antibody to CD11b+ as represented by the brown 
chromophore staining amongst the epithelium and in the lamina propria. (F) NF-κB staining 
in the colon of a cat with small cell GI LSA. Longitudinal and cross sectional views of 
colonic mucosa and lamina propria after IHC staining with a canine cross-reactive 
monoclonal antibody against NF-κB as represented by the brown chromophore staining 
amongst the epithelium and in the lamina propria. All scale bars, 200 m 
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CHAPTER 3. RESULTS  
Final Histopathologic Diagnoses 
 
 
     Fourteen cats were diagnosed with IBD based on histopathologic assessment of the 
mucosal cellular infiltrate (lymphoplasmacytic) after H&E, immunophenotypic staining and 
PARR as an adjunct diagnostic in equivocal cases. GI biopsies in 9 of 14 of these cats 
exhibited a 30% to 60% heterogenous population of small to intermediate lymphocytes and 
plasma cells invading the lamina propria, with mild but varying numbers of neutrophilic and 
eosinophilic cellular infiltrates per any given 400x magnification field assessed after H&E 
staining via microscopy. The diagnosis of IBD in these cats was supported by IHC showing 
relatively evenly mixed CD3 and CD21 or CD79a cellular positivity without 
immunophenotypic evidence of clustering of either T-cell or B-cell populations. Sparse 
numbers of intraepithelial lymphocytes (i.e. approximately 0 to 20 per 100 villous 
enterocytes) were also appreciated in limited villous epithelium and less commonly in crypt 
epithelium. Additionally, PARR was performed on intestinal biopsies from the remaining 5 
of these 14 cats to confirm diagnosis of a polyclonal lymphocyte mucosal population, as 
these biopsies were assessed as having areas of mild to moderate villous blunting and fusion 
with crypt effacement on histopathologic assessment, greater numbers of intraepithelial 
lymphocytes in both villous and crypt epithelium and rare, patchy areas of moderately heavy 
monomorphous lymphoid infiltrates of small to intermediate-sized CD3 staining 
lymphocytes. 
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     Fourteen cats were diagnosed with small cell GI LSA based on H&E stains and 
immunophenotyping, with 1 cat requiring PARR to confirm a final diagnosis. Thirteen of 
these 14 cats showed histopathologic evidence of moderate to marked villous blunting and 
fusion with crypt effacement after H&E staining. Moderate to marked intraepithelial villous 
and crypt lymphocytes (i.e. more than 40 per 100 villous enterocytes) and diffuse heavy 
effacement of the lamina propria with a heavy monomorphous lymphoid infiltrate of small to 
intermediate-sized CD3 staining lymphocytes, occasionally with sparse CD21/CD79a 
positive cells, were also appreciated after IHC staining. The occasional sparse CD21/CD79a 
positive cells were suspected to represent a mild inflammatory background. The 1 cat that 
required PARR to confirm the diagnosis of small cell GI LSA was assessed as having similar 
villous and crypt histopathologic features but exhibited a mild number of eosinophils and 
neutrophils infiltrating the lamina propria, minimal intraepithelial lymphocytes and patchy 
areas of monomorphous lymphoid infiltrate with varying areas of mixed T and B-cell 
populations, suggesting possible polyclonality. 
 
     Of the 14 cats diagnosed with IBD, 7 were castrated male and 7 were spayed female. Nine 
of these cats were domestic shorthairs, and there was 1 cat each of domestic longhair, Lynx 
Point, Savannah, Siamese, and Ocicat. Of the 14 cats diagnosed with small cell GI LSA, 6 
were castrated male, 7 were spayed female, and sex and neuter statuses were not reported in 
the medical record for 1 cat. Eleven of these cats were domestic shorthairs, and there was 1 
cat each of domestic longhair, Himalayan, and Maine Coon. Histories were available for all 
28 cats. Duration of clinical signs for each cat was reported as at least 3 weeks prior to  
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presentation. Clinical signs of vomiting (n = 24) and weight loss (n = 13) were noted most 
frequently with some cats also exhibiting variable hyporexia (n = 9), small bowel diarrhea, 
large bowel diarrhea, or both (n = 10) and hematochezia (n = 2). In general, cats with small 
cell GI LSA were older than cats with IBD (small cell GI LSA: mean 10.9, standard 
deviation 3.35; IBD: mean 7.4, standard deviation 3.68; P = 0.009). Serum T4 measurements 
were within reference range for all cats (n = 28). Cats in which FeLV and FIV status were 
assessed (10 cats with IBD, and 14 cats with small cell GI LSA) were all negative. Serum 
cobalamin measurements were available for 11 cats (5 with IBD and 6 with small cell GI 
LSA). One of the 5 cats with IBD with reported serum cobalamin concentrations had a 
cobalamin level less than 300ng/L and 4 of the 6 small cell GI LSA cats with reported serum 
cobalamin concentrations had cobalamin measurements less than 300ng/L. Abdominal 
ultrasound findings were available in 22 of the 28 cats (10 cats with IBD and 12 cats with 
small cell GI LSA). The remaining 6 cats either did not have abdominal imaging performed 
or the report was excluded from the medical records. Of the cats with abdominal ultrasounds 
performed, 10 had normal gastrointestinal wall thickness (7 cats with IBD and 3 cats with 
small cell GI LSA) and 12 had diffuse thickening of the GI muscularis (3 cats with IBD and 
9 cats with small cell GI LSA). Five of the cats with IBD and 9 of the cats with small cell GI 
LSA had enlarged mesenteric lymph nodes. In the remaining cats with abdominal imaging 
performed, lymph nodes were noted as normal in size. 
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Quantification and Spatial Distribution of Mucosal Bacteria Determined by 
Fluorescence in Situ Hybridization 
 
 
     Only few bacteria were identified as invasive within the intestinal mucosal biopsies. 
Therefore, bacterial quantification was performed in the 3 other mucosal compartments (free 
mucus, adherent mucus, attaching to surface epithelia) (Table 2) and separately in adherent 
mucus (Table 3), in both the ileal and the colonic biopsies. Gastrointestinal biopsies of cats 
with small cell GI LSA had significantly increased numbers of total Fusobacterium spp. 
bacteria in the 3 combined mucosal compartments of the colon (P = 0.017) compared to GI 
biopsies of cats with IBD (Table 2). Total Fusobacteria spp. bacteria in the 3 combined 
mucosal compartments of ileal biopsies of cats with small cell GI LSA was not statisticaly 
significanct (P = 0.059) compared to ileal biopsies of cats with IBD (Table 2). 
Gastrointestinal biopsies of cats with small cell GI LSA had significantly increased numbers 
of total Fusobacteria spp. bacteria in the adherent mucus compartments of the ileum (P = 
0.046) and colon (P = 0.016) versus GI biopsies of cats with IBD (Table 3). There was a 
significantly increased number of Bacteroides spp. bacteria in the 3 combined ileal mucosal 
compartments (P = 0.034) (Table 2) and in the ileal adherent mucus (P = 0.036) (Table 3) of 
GI biopsies of cats with small cell GI LSA compared to GI biopsies of cats with IBD. The 
numbers of total bacteria, Clostridium spp., Enterobacteriaceae, Helicobacter spp. and 
Faecalibacterium spp. were not significantly different when comparing the colonic and ileal 
biopsies of cats with IBD relative to the biopsies of cats with small cell GI LSA. 
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     The amount of each species of bacteria evaluated were subjectively observed to be more 
prevalent in the adherent mucus layer versus the free mucus, attached to the surface epithelia, 
and invasive within the mucosa, including for Fusobacterium spp. and Bacteroides spp. 
bacteria (Figure 3 and 4). 
 
Number of Mucosal CD11b+ Myeloid Cells and NF-B Expression 
 
Cats with small cell GI LSA had significantly increased numbers of CD11b+ cells within the 
lamina propria of both ileal (median = 503; min 30, max 1985; P = 0.012) and colonic 
biopsies (median = 77; min 13, max 2858; P < 0.0001) versus cats with IBD (Figure 5). Cats 
with small cell GI LSA also had significantly increased expression of NF-B in the lamina 
propria of both ileal (median = 750; min 69, max 2227; P = 0.0055) and colonic biopsies 
(median = 154; min 40, max 3581; P < 0.0001) when compared to cats with IBD (Figure 6). 
Additionally, data analysis showed a positive correlation between the total numbers of 
Fusobacterium spp. bacteria and the total numbers of CD11b+ cells (P = 0.009; rs 0.476) as 
well as cells expressing NF-B (P = 0.004; rs 0.523) as assessed by spearman correlation 
coefficients. 
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Table 2. Total bacteria in 3 combined compartments (free mucus, adherent mucus, attaching 
to surface epithelia). Data has been logged transformed to control for variability, and are 
reported as mean and standard deviation of the transformed data. 
Probe Group             Ileum     Colon 
Eub338  
 
Erec482 
IBD 
LSA 
IBD 
5.52 ± 1.92 
6.75 ± 0.37 
4.95 ± 2.13 
6.56 ± 0.65 
6.55 ± 0.39 
5.59 ± 1.23 
 
Ebac1790 
LSA 
IBD 
6.19 ± 0.77 
4.36 ± 2.47 
5.86 ± 0.78 
4.33 ± 1.87 
 
Bacto1080 
LSA 
IBD 
3.98 ± 1.75 
5.64 ± 1.01 
4.80 ± 1.14 
5.91 ± 1.59 
 
Hel717 
LSA 
IBD 
6.60 ± 0.38a 
1.54 ± 1.60 
6.00 ± 1.17 
1.97 ± 1.82 
 
Faecali698 
LSA 
IBD 
2.07 ± 1.07 
4.62 ± 2.13 
2.27 ± 1.71 
5.12 ± 1.71 
 
Fuso0664 
LSA 
IBD 
5.95 ± 0.75 
4.60 ± 2.14 
5.35 ± 1.27 
5.14 ± 1.27 
 LSA 6.32 ± 0.52 6.14 ± 0.66b 
IBD, inflammatory bowel disease cats; LSA, small cell gastrointestinal lymphoma cats. 
(total = 28 cats; IBD = 14 cats; small cell GI LSA = 14 cats).  
aMean Bacteroides spp. bacterial count in ileal biopsies of small cell GI LSA cats 
significantly higher than in ileal biopsies of cats with IBD (P = 0.034).  
bMean Fusobacterium spp. bacterial count in colonic biopsies of small cell GI LSA cats 
significantly higher than in colonic biopsies of cats with IBD (P = 0.017).  
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Table 3. Total bacteria in adherent mucus. Data has been logged transformed to control for 
variability, and are reported as mean and standard deviation of the transformed data. 
Probe Group                           Ileum Colon 
Eub338 
 
Erec482 
IBD 
LSA 
IBD 
5.33 ± 2.04 
6.72 ± 0.38 
4.90 ± 2.11 
6.51 ± 0.66 
6.50 ± 0.41 
5.51 ± 1.33 
 
Ebac1790 
LSA 
IBD 
LSA 
6.09 ± 0.97 
4.34 ± 2.46 
3.67 ± 2.13 
5.80 ± 0.81 
4.25 ± 1.91 
4.72 ± 1.18 
Bacto1080 
 
IBD 
LSA 
5.43 ± 1.23 
6.57 ± 0.38a  
5.76 ± 1.86 
5.95 ± 1.25 
Hel717 IBD 1.45 ± 1.53 1.86 ± 1.70 
 
Faecali698 
LSA  
IBD 
LSA  
1.99 ± 1.10 
4.57 ± 2.13 
5.94 ± 0.74 
2.04 ± 1.82 
5.03 ± 1.72 
5.20 ± 1.59 
Fuso0664 IBD 4.40 ± 2.18 5.06 ± 1.29 
 LSA 6.28 ± 0.56b 6.10 ± 0.70c 
IBD, inflammatory bowel disease cats; LSA, small cell gastrointestinal lymphoma cats. (total 
= 28 cats; IBD = 14 cats; small cell GI LSA = 14 cats). 
aMean Bacteroides spp. bacterial count in ileal biopsies of small cell GI LSA cats significantly 
higher than in ileal biopsies of cats with IBD (P = 0.036). 
bMean Fusobacterium spp. bacterial count in ileal biopsies of small cell GI LSA cats 
significantly higher than in ileal biopsies of cats with IBD (P = 0.046). 
cMean Fusobacterium spp. count in colonic biopsies of small cell GI LSA cats significantly 
higher than in colonic biopsies of cats with IBD (P = 0.016)   
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Figure 3.A Three-color fluorescence in situ hybridization (FISH) of Fusobacterium spp. 
identified in colonic biopsies of a cat with small cell GI LSA. Cy-3-labeled Fusobacterium 
spp. (labeled orange) localized within adherent mucus of a colonic biopsy specimen. The 
mucus is also occupied by other bacteria (total bacteria labeled green with FITC-Eub). The 
dark blue structures are epithelial cell nuclei stained with DAPI. Figure 3.B Three-color 
fluorescence in situ hybridization (FISH) of Fusobacterium spp. identified in colonic 
biopsies of a cat with IBD. Cy-3-labeled Fusobacterium spp. (labeled orange) localized 
within adherent mucus of a colonic biopsy specimen. The mucus is also occupied by other 
bacteria (total bacteria labeled green with FITC-Eub). The dark blue structures are epithelial 
cell nuclei stained with DAPI. 
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Figure 4.A Three-color fluorescence in situ hybridization (FISH) of Bacteroides spp. 
identified in ileal biopsies of a cat with small cell GI LSA. Cy-3-labeled Bacteroides spp. 
(labeled orange) localized within adherent mucus of an ileal biopsy specimen. The mucus is 
also occupied by other bacteria (total bacteria labeled green with FITC-Eub). The dark blue 
structures are epithelial cell nuclei stained with DAPI. Figure 4.B Three-color fluorescence in 
situ hybridization (FISH) of Bacteroides spp. identified in ileal biopsies of a cat with IBD. 
Legend: Cy-3-labeled Bacteroides spp. (labeled orange) localized within adherent mucus of 
an ileal biopsy specimen. The mucus is also occupied by other bacteria (total bacteria labeled 
green with FITC-Eub). The dark blue structures are epithelial cell nuclei stained with DAPI. 
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Figure 5 Mucosal CD11b+ cellular expression in cats with IBD compared to cats with small 
cell GI LSA in the ileum and colon (total = 28 cats). 
Boxes show lowest, median, and upper quartiles. Whiskers represent 1.5 of the interquartile 
range, with means denoted by the black rhombi and outliers denoted by the black circles. 
Median mucosal CD11b+ myeloid cell counts are significantly higher in the ileum and colon 
of cats with small cell GI LSA compared to cats with IBD (P < 0.05). 
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Figure 6 Mucosal NF-B cellular expression in cats with IBD compared to cats with small 
cell GI LSA in the ileum and colon (total = 28 cats). 
Boxes show lowest, median, and upper quartiles. Whiskers represent 1.5 of the interquartile 
range, with means denoted by the black rhombi and outliers denoted by the black circles. 
Median NF-B mucosal expression is significantly higher in the ileum and colon of cats with 
small cell GI LSA when compared to cats with IBD (P < 0.05). 
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CHAPTER 4. DISCUSSION 
 
 
     Major bacterial phyla identified in feces of healthy cats include Enterobacteriaceae, 
Bacteroides spp., Helicobacter spp., Fusobacterium spp. and members of Firmicutes, 
including Clostridium spp. clusters IV and XIVa, and Faecalibacterum spp.37,39,49,57  
Compared to earlier studies performed in healthy cats, we chose to investigate the spatial 
distribution of the mucosal microbiota of ileal and colonic biopsies using FISH techniques in 
2 important and clinically overlapping disease cohorts, cats with IBD and cats with small cell 
GI LSA. Our results indicate that the numbers of mucosa-associated Fusobacterium spp. and 
Bacteroides spp. were increased in the ileal biopsies of cats with small cell GI LSA 
compared to the ileal biopsies of cats with IBD, while the numbers of mucosa-associated 
Fusobacterium spp. bacteria were also increased in the colonic biopsies of cats with small 
cell GI LSA compared to cats with IBD. Furthermore, the numbers of Fusobacteria spp. in 
adherent mucus were strongly associated with increased numbers of CD11b+ cells and up-
regulated mucosal expression of NF-B in GI biopsies of cats with small cell GI LSA 
compared to GI biopsies of cats with IBD.  
 
     In humans, some Fusobacterium spp., including Fusobacterium nucleatum, have been 
associated with an increased risk for colorectal and pancreatic cancers, as well as some oral 
squamous cell carcinomas.38,42,44,52  Fusobacterium nucleatum numbers are significantly 
correlated with tumor size, and shortened survival times in a population of human Japanese 
patients with later stage CRC compared to earlier stages.53  These findings, as well as  
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additional observations in rodent models and humans with CRC suggest that chronic 
inflammatory disease of the GI tract is a potential risk factor for the development of 
additional channels for amplified inflammatory processes, aneuploidy, high-grade dysplasia, 
metaplasia and loss of cellular proliferative checkpoints, all of which are processes that can 
be appreciated in malignancy.13,19,54,58,59  The increased numbers of mucosal Fusobacterium 
spp. bacteria in GI biopsies of cats with GI LSA relative to GI biopsies of cats with IBD 
noted in the current study, although possibly just an effect of the GI malignancy, could also 
be associated with a potential progression from high grade chronic lymphoplasmacytic 
inflammation to inflammation-mediated lymphoid intestinal cancer. 
 
     Although incompletely understood, GI inflammation-mediated progression to cancer 
development might involve bacterial toxin production, release of alarmins, gut biofilm 
modification, dysregulation of gut barrier function, suppression of anti-inflammatory 
mediators and transition through an element of high grade dysplasia to cell damage and 
aneuploidy.13,19,35,40,60-62  Fusobacterium spp. is pro-inflammatory, exhibits adhesive and 
invasive properties via virulence factors (i.e., FadA, fusobacterium autotransporter protein 2 
and fusobacterial outer membrane protein A), and promotes pro-oncogenic features which 
might contribute to accelerated tumor growth and tumor burden.38,47,54  Increased 
Fusobacterium nucleatum is associated with an increase in adenoma formation and 
accelerated small intestinal adenocarcinoma development in rodent models of GI neoplasia.41  
Coupled with this was an expansion of CD11b+ myeloid cells (i.e., dendritic cells, 
macrophages, and myeloid-derived suppressor cells) in the neoplastic tissues and an NF-B- 
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driven pro-inflammatory response.41  Similarly, our results also indicated increases in 
CD11b+ and NF-B expressing cells in GI biopsies of cats with small cell GI LSA, and there 
was a positive correlation between increased Fusobacterium spp. numbers and both CD11b+ 
and NF-B expressing cells. Furthermore, CD11b+ myeloid cells might contribute to 
development of a tumor microenvironment,19,63 and Fusobacterium spp. might induce toll 
like receptors (TLR), to stimulate NF-B through the TLR4/MYD88 pathway.54  
Importantly, TLRs are found on both immune and non-immune cells, and can be expressed 
on tumors including human mantle cell lymphoma.21,64 
 
     There were also increased numbers of the Bacteroides-Prevotella bacteria in the ileal 
biopsies of the cats with small cell GI LSA compared to ileal biopsies of the cats with IBD. 
Prior studies have shown that increased Bacteroides spp. can be seen in healthy cats versus 
cats with IBD.65,66  This suggests that progressive disease might be associated with a 
decreased Bacteroides spp. load. This difference in findings might be explained by the 
different sampling sites (mucosal versus fecal) that were used for Bacteroides spp. 
quantification,67  or might be due to the different cohorts compared, considering that 
quantification of GI Bacteroides spp. in cats with GI small cell LSA, to the authors’ 
knowledge, has not been previously evaluated. Also, as the Bacteroides spp. incorporates a 
number of different subspecies, there is also the possibility that cats with small cell GI LSA 
harbor increased numbers of enterotoxigenic Bacteroides spp. as compared to those with 
IBD, as occurs in humans.68,69 
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     The additional 5 probes evaluated using FISH included Clostridium spp. (Erec482), 
Enterobacteriaceae (Ebac1790), Helicobacter spp. (Hel717), Faecalibacterium spp. 
(Faecali896) and total bacteria (Eub338). Clostridium spp. population and diversity have 
been shown to be decreased while Enterobacteriaceae bacteria is increased in humans, dogs 
and cats with chronic intestinal inflammation.16,17,65,70-72  Utilizing 16S rRNA sequencing in 
cats with chronic enteropathies, Faecalibacterium spp. bacteria were decreased while 
Enterobacteriaceae numbers were increased in cats with diarrhea.66  This variation of 
bacterial species also occurs in dogs with IBD.72,73  Therefore, different inflammatory states 
are characterized by differences in the microbiota. The current study did not show any 
significant differences in Enterobacteriaceae, Faecalibacterium spp. and total bacteria 
(Eub338) in GI biopsies of cats with small cell GI LSA compared to GI biopsies of cats with 
IBD. 
 
     Helicobacter spp. induces host responses influencing risk of oncogenesis, and promotes 
chronic gut inflammation in humans and mice.46  In a recent study, FISH showed that the 
presence of enterohepatic helicobacter was significantly associated with poorly differentiated 
large intestinal adenocarcinoma in cats.48  Our results showed no significant difference in 
Helicobacter spp. bacterial counts in GI biopsies of cats with small cell GI LSA compared to 
GI biopsies of cats with IBD. 
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     It should be noted that in this study the majority of bacteria evaluated were located in the 
adherent mucus of the GI biobsies, a finding consistent with a prior study.10 Less bacteria  
was appreciated in the free mucus and attaching to the surface epithelium, although still 
subjectively substantial. In a number of the biopsies there was very minimal to no bacteria 
appreciated invasively in the mucosa. 
 
     Although there is clinical relevance in determining the short and long-term outcomes and 
response to treatment of the underlying enteropathy in cats with alterations in the GI 
microbiota, we were unable to fully assess the significance of the relationship of 
Fusobacterium spp. quantification and outcome due to the variation of treatments and the 
limitation on follow up for a number of these cats. This is worth assessing in future studies, 
as in human studies and rodent models, overabundance of Fusobacterium spp. in patients or 
rodents with CRC does appear to have a correlation with poorer prognostic outcome.36,51,54  
 
     There are a number of potential limitations to this study. These would include the 
retrospective study design using medical records completed by different clinicians and the 
small population of cats evaluated. As diagnosis of IBD and small cell GI LSA rely as much 
on prior history as diagnostic findings the authors included, at a minimum, the most pertinent 
historical findings that would be needed to make these diagnoses in light of findings 
associated with diagnostic testing performed. The administration of antibiotics that could 
have affected the microbiota would be another potential limitation. The authors attempted to 
include cats with no history of antibiotic administration 2 weeks prior to the acquisition of GI  
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biopsies but this information was not always reported in the medical records. Processing, 
including formalin-fixation and paraffin embedding of the biopsies, might have also played a 
role in the finding of bacteria contained in the adherent mucus compartment, but this is 
consistent with a prior study10 and should not have caused a discrepancy in any 1 cat in the 
study relative to the study population as a whole. Another potential limitation was the 
inability to perform PARR on the formalin-fixed, paraffin embedded tissues of all cats. The 
authors acknowledge that both PARR and IHC, when utilized together could have reduced 
the underestimation of small cell GI LSA in this population and might have allowed for a 
more sensitive means of screening for small cell GI LSA amongst the cohorts.2,74 
Unfortunately, tissue specimens were sometimes too limited per each feline endoscopic 
biopsy sample to allow for this additional diagnostic, due to the extensive tissue requirement 
for both hybridization for FISH and CD11b+ and NF-B immunohistochemical assessment. 
Also, the expense of performing PARR on all samples in this study would have been beyond 
the scope of funds available for the study. The authors did attempt to circumvent this 
limitation by performing PARR on any sample that exhibited questionable lymphoid 
monomorphism. Furthermore, it has been suggested that although PARR is valuable as a 
differentiating diagnostic test, it should be considered as an adjunct to immunohistochemical 
and histologic diagnostics, as it also does have its limitations relative to false negatives.2,74 It 
has been recommended that PARR be considered as part of a stepwise diagnostic strategy, 
indicating the importance of more advanced testing only as required in a true clinical 
setting.2,74 
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     In conclusion, we showed that Fusobacterium spp. bacteria are increased in the ileum and 
colon of GI biopsies of cats with small cell GI LSA relative to GI biopsies of cats with IBD. 
We also showed that increased Fusobacterium spp. bacteria are positively correlated to 
increased CD11b+ and NF-B expression in neoplastic ileal and colonic biopsies versus ileal 
and colonic biopsies of cats with lymphoplasmacytic ileitis and colitis (idiopathic IBD). 
Future studies would be needed to attempt to further clarify whether increased 
Fusobacterium spp is a consequence of small cell GI LSA in cats or whether it plays a role in 
the development of the disease. 
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